|Grant ID: RR150072|
Recruitment of Established Investigators
University of Chicago
August 19, 2015
Most conventional therapies for cancer, including chemotherapy and radiation, damage immune cells at the same time as they kill cancer cells—sort of like killing your enemy and your troops at the same time. Relapse rates can be high for some cancers, even if the therapy is initially effective.
Immune therapy holds greater promise for a long-term cure for cancer, but is currently only effective in 20-40% of patients. Dr. Yang-Xin Fu, M.D., Ph.D., believes that immune therapies could be made more effective with a new combination approach, which would also recruit immune cells to tumors at the same time as revving up their effectiveness.